| 742358 |
FRONTIERS IN ONCOLOGY |
Ex Vivo Drug Screening Informed Targeted Therapy for Metastatic Parotid Squamous Cell Carcinoma |
2021-09-16 |
10.3389/fonc.2021.735820 |
Nykänen Noora, Mäkelä Rami, Arjonen Antti, Härmä Ville, Lewandowski Laura, Snowden Eileen, Blaesius Rainer, Jantunen Ismo, Kuopio Teijo, Kononen Juha, Rantala Juha K. |
| 742357 |
FRONTIERS IN ONCOLOGY |
Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells—Report on Two Cases |
2021-09-16 |
10.3389/fonc.2021.737645 |
Gerhardt Kristin, Jentzsch Madlen, Georgi Thomas, Sretenović Aleksandra, Cross Michael, Bach Enrica, Monecke Astrid, Leiblein Sabine, Hoffmann Sandra, Todorović Milena, Bila Jelena, Sabri Osama, Schwind Sebastian, Franke Georg-Nikolaus, Platzbecker Uwe, Vučinić Vladan |
| 742356 |
FRONTIERS IN ONCOLOGY |
A Novel Seven Gene Signature-Based Prognostic Model to Predict Distant Metastasis of Lymph Node-Negative Triple-Negative Breast Cancer |
2021-09-16 |
10.3389/fonc.2021.746763 |
Peng Wenting, Lin Caijin, Jing Shanshan, Su Guanhua, Jin Xi, Di Genhong, Shao Zhiming |
| 742355 |
FRONTIERS IN ONCOLOGY |
The Learning Curve of Computer-Assisted Free Flap Jaw Reconstruction Surgery Using 3D-Printed Patient-Specific Plates: A Cumulative Sum Analysis |
2021-09-16 |
10.3389/fonc.2021.737769 |
Zhu Wang-yong, Choi Wing Shan, Wong May Chun Mei, Pu Jingya Jane, Yang Wei-fa, Su Yu-xiong |
| 742354 |
FRONTIERS IN ONCOLOGY |
Safety and Efficacy of Anti-CD19-Chimeric Antigen Receptor T Cell Combined With Programmed Cell Death 1 Inhibitor Therapy in a Patient With Refractory Post-Transplant Lymphoproliferative Disease: Case Report and Literature Review |
2021-09-16 |
10.3389/fonc.2021.726134 |
Feng Gang, Li Qing, Zhu Haibo, Jiang Yanyu, Yuan Jijun, Fu Yingxin, Deng Qi |
| 742353 |
FRONTIERS IN ONCOLOGY |
The Clinical Significance of Mesenteric Lymphocytes in Human Colorectal Cancer |
2021-09-16 |
10.3389/fonc.2021.685577 |
Wu Zi-Xin, Wang Fei, Li Liang, Yao Yuan, Long Jie, Luo Qing-Qing, Zhao Zhi-Bin, Li Wang-Lin, Cao Jie, Lian Zhe-Xiong |
| 742352 |
FRONTIERS IN ONCOLOGY |
Recurrence Patterns After IMRT/VMAT in Head and Neck Cancer |
2021-09-16 |
10.3389/fonc.2021.720052 |
Bollen Heleen, van der Veen Julie, Laenen Annouschka, Nuyts Sandra |
| 742351 |
FRONTIERS IN ONCOLOGY |
Advanced Nano-Carriers for Anti-Tumor Drug Loading |
2021-09-16 |
10.3389/fonc.2021.758143 |
Xiang Jia, Zhao Rui, Wang Bo, Sun Xinran, Guo Xu, Tan Songwen, Liu Wenjie |
| 742350 |
FRONTIERS IN ONCOLOGY |
Prognostic Value of Plasma Epstein-Barr Virus DNA Levels Pre- and Post-Neoadjuvant Chemotherapy in Patients With Nasopharyngeal Carcinoma |
2021-09-16 |
10.3389/fonc.2021.714433 |
Zhu Lisheng, Ouyang Tao, Xiong Ying, Ba Li, Li Qiuting, Qiu Mengjun, Zou Zhenwei, Peng Gang |
| 742349 |
FRONTIERS IN ONCOLOGY |
Electrochemotherapy as a Trigger to Overcome Primary Resistance to Anti-PD-1 Treatment: A Case Report of Melanoma of the Scalp |
2021-09-16 |
10.3389/fonc.2021.742666 |
Quaresmini Davide, Di Lauro Alessandra, Fucci Livia, Strippoli Sabino, De Risi Ivana, Sciacovelli Angela Monica, Albano Anna, Achille Gaetano, Montepara Massimo, Russo Sabino, Tassone Gabriella, Guida Michele |
